These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2716260)

  • 41. [Campylobacter pylori colonization of the antrum mucosa in patients with chronic gastritis and peptic ulcer].
    Brunner H; Mittermayer H; Regele H
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():20-3. PubMed ID: 3318189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chronic gastritis associated with peptic ulcer: an endoscopic and histological study].
    Lambert R; Moulinier B; Van-Den-Put F; Grenier-Boley P; Bruhière J
    Arch Fr Mal App Dig; 1973; 62(1):53-9. PubMed ID: 4741121
    [No Abstract]   [Full Text] [Related]  

  • 43. [Bismuth aluminate in gastroenterology. Therapeutic effects in chronic erosive Campylobacter pylori-associated gastritis].
    Stanescu A; Malfertheiner P; Mayer D; Baczako K; Ditschuneit H
    Fortschr Med; 1989 Oct; 107(29):623-6. PubMed ID: 2680842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
    Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
    Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The characteristics of duodenogastric reflux in peptic ulcer and chronic gastritis].
    Danilov AS; Reshetnikov OV; Kurilovich SA
    Ter Arkh; 1994; 66(2):43-5. PubMed ID: 8160143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helicobacter pylori infection after gastrectomy and vagotomy in duodenal ulcer patients.
    Sito E; Konturek PC; Konturek SJ; Bielański W; Stachura J
    J Physiol Pharmacol; 1996 Mar; 47(1):229-37. PubMed ID: 8777304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Helicobacter pylori in peptic ulcer and gastric cancer].
    Matsukura N; Onda M; Yamashita K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of gastroduodenal ulcer in gastritis.
    Sipponen P
    Mater Med Pol; 1990; 22(2):105-7. PubMed ID: 2102971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics.
    Arkkila PE; Kokkola A; Seppälä K; Sipponen P
    Scand J Gastroenterol; 2007 Jun; 42(6):695-701. PubMed ID: 17505991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Campylobacter pyloridis gastritis: the past, the present, and speculations about the future.
    Graham DY; Klein PD
    Am J Gastroenterol; 1987 Apr; 82(4):283-6. PubMed ID: 3551584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori].
    Lokhvitskiĭ SV; Darvin VV; Proshin AV; Bashirova ES; Butorov IL
    Vestn Khir Im I I Grek; 1998; 157(2):18-20. PubMed ID: 9691374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detection of pyloric Campylobacter in patients with gastroduodenal diseases].
    Ramírez-Ramos A; León-Barúa R; Gilman R; Spira W; Recavarren S; Watanabe J; Stephensen C; Cok J; Quevedo N; Rodríguez Ulloa C
    Acta Gastroenterol Latinoam; 1986; 16(1):9-22. PubMed ID: 3554873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of gastric mucosal lesions in patients with celiac disease: a prospective controlled study.
    Diamanti A; Maino C; Niveloni S; Pedreira S; Vazquez H; Smecuol E; Fiorini A; Cabanne A; Bartellini MA; Kogan Z; Valero J; Mauriño E; Bai JC
    Am J Gastroenterol; 1999 May; 94(5):1313-9. PubMed ID: 10235212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastroduodenal mucosa in peptic ulcer: endoscopic and histological assessment.
    Chattopadhyay G; Basu K; Mukherjee S; Hazra BR
    Trop Gastroenterol; 1997; 18(4):156-9. PubMed ID: 9612096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Campylobacter pyloridis in duodenal ulcer].
    Loginov AS; Smotrova IA; Il'chenko AA; Aruin LI
    Sov Med; 1989; (3):3-6. PubMed ID: 2734670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Campylobacter pyloridis--a possible etiologic agent in patients with chronic gastritis and peptic ulcer].
    Kalenić S; Falisevac V; Gmajnicki B; Scukanec-Spoljar M; Knezević S; Vodopija I
    Lijec Vjesn; 1987 Jul; 109(7):256-60. PubMed ID: 3669886
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the pathogenesis and treatment of erosive gastritis and duodenitis].
    Vakhrushev IaM; Nikishina EV
    Klin Med (Mosk); 1999; 77(2):28-31. PubMed ID: 10380457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.